SAN DIEGO, Sept. 18, 2012 /PRNewswire/ -- Accelrys, Inc. (NASDAQ: ACCL), a leading provider of scientific innovation lifecycle management software, today announced the new integrated Accelrys Process Management and Compliance Suite of software products designed specifically to enhance product and process insight, facilitate collaboration and streamline product development from research through late-stage quality control and manufacturing. By improving the way businesses manage the scientific innovation lifecycle, the suite helps bring products to market faster and at a lower cost, while meeting critical quality and regulatory compliance objectives.

To view the multimedia assets associated with this release, please click http://www.prnewswire.com/news-releases/accelrys-transforms-lab-to-commercialization-process-with-new-integrated-accelrys-process-management-and-compliance-suite-170108246.html

"Companies that rely on science to innovate continue to struggle with quickly and cost-effectively transforming good ideas into successful products," said Accelrys president and chief executive officer Max Carnecchia. "The unified approach to product development and process execution offered by the Accelrys Process Management and Compliance Suite provides a transformative path forward for organizations demanding new ways to accelerate innovation and retain competitive advantages."

The Accelrys Process Management and Compliance Suite directly integrates with systems critical to development and manufacturing processes such as laboratory information management systems (LIMS), enterprise resource planning (ERP), product lifecycle management (PLM) and manufacturing execution systems (MES). The ability to leverage existing applications and infrastructure, combined with the features of the Accelrys Process Management and Compliance Suite, offers organizations for the first time a single, unified source for harmonizing critical-path data and meeting the "right-first-time" needs of downstream manufacturing. The insights gained from the suite enhance reporting, decision making, knowledge management and operational excellence from lab to commercialization.

The Accelrys Process Management and Compliance Suite is the result of Accelrys' 2012 acquisition of VelQuest Corporation with its industry-leading paperless lab execution and data capture technology. The integrated suite comprises:

  • Accelrys Enterprise Platform
  • Accelrys Lab Execution System
  • Accelrys Electronic Lab Notebook (formerly Symyx Notebook by Accelrys)
  • Accelrys Electronic Batch Records

"For too long lab-to-market value chain processes have been managed by an outmoded combination of disconnected point solutions, paper notebooks and home-grown tools, creating a productivity gap that has slowed innovation," said Ken Rapp, managing director of Accelrys' analytical, development, quality and manufacturing solutions. "The Accelrys Process Management and Compliance Suite changes that paradigm. By combining the capabilities of an electronic lab notebook, lab execution system and an enterprise scientific informatics platform, Accelrys brings a holistic approach to solving common and costly operational challenges ranging from production quality issues and regulatory violations to shrinking margins."

Integration of the Accelrys Process Management and Compliance Suite with the Accelrys Enterprise Platform enables lifecycle aggregation, analytics and comprehensive reporting across the continuum from discovery to manufacturing, supporting Six Sigma and Quality by Design (QbD) programs and International Conference on Harmonization (ICH) initiatives in pharmacovigilance and risk management.

The Accelrys Process Management and Compliance Suite supports scientists working in early and mid-stage analytical, formulation and process/bioprocess development all the way through to stability, material and release testing during late-stage quality control and commercial production. By ensuring seamless technology transfer at the crucial research, development, pilot and manufacturing handoffs, the suite enables the rapid and accurate transfer of methods, recipes and procedures captured during early development into automated execution. As a result, customers have reported that they are experiencing up to 25 percent productivity improvement while cutting cycle times in half and reducing compliance risks.

To learn more about the Accelrys Process Management and Compliance Suite, visit the overview page, download the solution brief and register for future webinars coming soon on this innovative solution for accelerating science to compliance.

About Accelrys, Inc.

Accelrys (NASDAQ: ACCL), a leading provider of scientific innovation lifecycle management software, supports industries and organizations that rely on scientific innovation to differentiate themselves. The industry-leading Accelrys Enterprise Platform provides a broad, flexible scientific solution optimized to integrate the diversity of science, experimental processes and information requirements across the research, development, process scale-up and early manufacturing phases of product development. By incorporating capabilities in applications for modeling and simulation, enterprise lab management, workflow and automation, and data management and informatics, Accelrys enables scientific innovators to access, organize, analyze and share data in unprecedented ways, ultimately enhancing innovation, improving productivity and compliance, reducing costs and speeding time from lab to market.

Accelrys solutions are used by more than 1,300 customers in the pharmaceutical, biotechnology, energy, chemicals, aerospace, consumer packaged goods and industrial products industries. Headquartered in San Diego, Calif., Accelrys employs more than 200 full-time PhD scientists. For more information about Accelrys, visit www.accelrys.com.

Related Links:

Accelrys Website 

YouTube

SOURCE Accelrys, Inc.

Copyright 2012 PR Newswire

Accelrys, Inc. (MM) (NASDAQ:ACCL)
Historical Stock Chart
From Oct 2024 to Nov 2024 Click Here for more Accelrys, Inc. (MM) Charts.
Accelrys, Inc. (MM) (NASDAQ:ACCL)
Historical Stock Chart
From Nov 2023 to Nov 2024 Click Here for more Accelrys, Inc. (MM) Charts.